The research conducted by scientists at the University of Sydney focused on the antimicrobial properties and chemical profiles of honey produced by Australian stingless bees, specifically Tetragonula carbonaria, Tetragonula hockingsi, and Austroplebeia australis. Their findings highlighted the high antimicrobial potential of these honeys against various human pathogens, comparable to or even surpassing European honey bee honeys. Unlike European honey bee honey that relies heavily on hydrogen peroxide for its antimicrobial effects, Australian stingless bee honey was noted for its robust nature with high levels of both hydrogen peroxide and non-peroxide activity. The study suggests that the antimicrobial properties of Australian stingless bee honey are intrinsic to the honey itself, showcasing consistent activity across different samples. This consistency and unique physicochemical characteristics could open doors for commercial medical applications. However, challenges in scalability due to small hive yields were acknowledged. Despite this, researchers believe that with the proper incentives and commercial value for the honey, cultivating more hives could lead to commercial scalability. Regulatory support for native stingless bee honey, as indicated by approval from Food Standards Australia New Zealand, provides a promising outlook for national and international commercialization. The establishment of a niche market for high-value stingless bee honey products is on the horizon, potentially offering a new avenue in the field of therapeutics. The research findings were published in the journal Applied and Environmental Microbiology, highlighting the significant antimicrobial activity and special characteristics of Australian stingless bee honey that could revolutionize the medical and honey production industries.